Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer (Q62110057)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer |
clinical trial |
Statements
A Phase I Study to Determine the Maximum Tolerated Dose of Daunoxome as Therapy for the Treatment of Metastatic Breast Cancer (English)
0 references
December 1997
0 references